The largest Insider Buys this week were for OPKO Health Inc. (OPK, Financial), GMS Inc. (GMS, Financial), Investors Real Estate Trust (IRET, Financial) and Royce Value Trust Inc. (RVT, Financial).
OPKO Health Inc. (OPK, Financial): Director Robert Scott Fishel bought 2,500 shares
Director Robert Scott Fishel bought 2,500 shares of OPK stock on July 11 at the average price of $6. The price of the stock has decreased by 2.33% since.
OPKO Health Inc. is an American pharmaceutical and medical test company. The company is mainly focused on diagnostics and pharmaceuticals, but also develops treatments for secondary hyperparathyroidism. The company has recently finished the patient recruitment for a Phase III trial against insufficiency in Vitamin D. In 2014, it acquired Laboratorio Arama de Uruguay. The company has a market capitalization of $3.28 billion, and as of July 13 it traded at $5.86.
On June 11 OPKO Health Inc. announced that it has completed enrollment of 110 subjects in a Phase 2b dose escalation trial of OPK88003 to treat type 2 diabetes and obesity. The drug is a once weekly injectable oxyntomodulin medicine with GLP-1 and glucagon dual agonist activity. Based on preclinical and Phase 2 data, the use of the drug once weekly with an optimized dosing regimen could more effectively improve glucose control and increase weight loss.
GMS Inc. (GMS, Financial): Sr. VP of Operations Richard Alan Adams bought 2,000 shares
Sr. VP of Operations Richard Alan Adams bought 2,000 shares of GMS stock on July 06 at the average price of $26.44. The price of the stock has decreased by 3.21% since.
GMS Inc. is an American distributor of wallboard and suspended ceilings systems. The company distributes over 20,000 unique products from the industry’s leading manufactures across the U.S. The company operates a network of subsidiary companies with over 190 distribution centers nationwide. The company has a market capitalization of $1.05 billion, and as of July 13 it traded at $25.59.
On June 28 GMS Inc. reported financial results for the 2018 fiscal fourth quarter and full year ended April 30, 2018. Revenues for the quarter increased 3.4% to $635.8 million from $615 million during the same quarter prior year. Net income declined to $9.9 million, or $0.24 per diluted share, compared to $14.3 million, or $0.34 per diluted share during the prior year quarter. Adjusted EBITDA decreased 3.9% for the quarter to $50.1 million from adjusted EBITDA of $52.1 million from the prior year quarter.
Investors Real Estate Trust (IRET, Financial): EVP and CFO John Kirchmann bought 18,000 shares
EVP and CFO John Kirchmann bought 18,000 shares of IRET stock on July 12 at the average price of $5.49. The price of the stock has decreased by 0.36% since.
Investors Real Estate Trust is an American real estate company focused on the ownership, management, acquisition, and development of apartment communities. The company owns interests in 90 communities comprising of 14,176 apartment homes. The company has a market capitalization of $653.15 million, and as of July 13 it traded at $5.47.
On June 27 Investors Real Estate Trust reported its fiscal fourth quarter 2018 results. Net loss for the quarter was $0.19 per share compared to net income of $0.23 during the prior year quarter. Funds from operations per share was $0.06 for the quarter compared to $0.07 during the prior year quarter.
Royce Value Trust Inc. (RVT, Financial): Director Charles M. Royce bought 26,586 shares
Director Charles M. Royce bought 26,586 shares of RVT stock on July 09 at the average price of $15.33. The price of the stock has increased by 2.61% since.
Royce Value Trust Inc. is an American diversified closed-end management investment company that specializes in small cap investing. The fund normally invests at least 65% of its assets in the equity securities of small cap companies which generally have stock market capitalizations ranging from $100 million to $3 billion. The company has a market capitalization of $1.34 billion, and as of July 13 it traded at $15.73.
On July 5 Royce Value Trust Inc. announced the successful completion of its common stock rights offering which expired on July 3, 2018. Fund stockholders received one non-transferable right for each whole share of common stock held of record as of May 30. Stockholders were entitled to subscribe for one new share of common stock for each ten rights held and stockholders who fully exercised their rights were also entitled to subscribe for those shares not purchased by other stockholders.
For the complete list of stocks that were bought by their company executives, go to: Insider Trades.
Disclosure: I do not own stock in any of the companies mentioned in the article.
